Overall, nearly 80% of the c-Myc mitochondrial targets that we identified in MCF7 cells in vitro were also transcriptionally elevated in human breast cancer cells in vivo (20 out of 26, ∼77%). This evidence concerns the gene MYC and breast carcinoma.